Hodgkin's Disease Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials

Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets
Conditions:   Diffuse Large B-Cell Lymphoma;   Chronic Lymphocytic Leukemia;   B Cell Malignancies;   Non-Hodgkin's Lymphoma Intervention:   Drug: ABBV-525 Sponsor:   AbbVie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2022 Category: Research Source Type: clinical trials